Viracta Therapeutics (Nasdaq: VIRX) closes, terminates employees, explores strategic options.

Unusual Whales
2025.02.05 22:21
In San Diego on February 5, 2025, Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company targeting virus-associated cancers globally, revealed it has let go of its employees and will be ceasing operations. As part of this decision, the company is considering different options for its development initiatives.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.